Skip to main content
Theraclion SA logo

Theraclion SA — Investor Relations & Filings

Ticker · ALTHE ISIN · FR0010120402 LEI · 9695007X7HA7A1GCYD29 PA Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2015-11-18 Regulatory Filings
Country FR France
Listing PA ALTHE

About Theraclion SA

https://www.theraclion.com/?_ga=2.14878…

Theraclion SA is a medical device company specializing in the development and marketing of non-invasive therapeutic solutions using High-Intensity Focused Ultrasound (HIFU). The company's technology, known as echotherapy, provides a non-surgical alternative for tissue ablation. Its flagship product, SONOVEIN®, is a robotic solution for the non-invasive treatment of varicose veins. The system uses external ultrasound beams to ablate the target vein without incisions, catheters, or sedation, allowing for immediate patient recovery. Theraclion also developed ECHOPULSE®, a system for the treatment of thyroid nodules and breast fibroadenomas. The company's core focus is on providing precise, non-invasive treatments that reduce risks and recovery time compared to traditional surgical procedures.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 85% confidence The document is a press release dated November 18, 2015, announcing that Theraclion's new BEAMOTION procedure obtained a CE Mark and was presented at the French Senology Congress. It details product development, regulatory milestones (CE Mark), and clinical validation, which are typical components of corporate news releases regarding product advancements and market access. This content does not fit the strict definitions of an Annual Report (10-K), Earnings Release (ER), Interim Report (IR), or a specific shareholder/board action. Since it is a general corporate announcement about a significant business event (product approval/feature), and it is not a transcript (CT), a formal financial filing, or a management discussion (MDA), it best fits the general 'Regulatory Filings' (RNS) category as a broad corporate announcement, although it functions similarly to an Investor Presentation (IP) or a specialized press release. Given the options, RNS serves as the best general regulatory/corporate announcement fallback for non-standard filings that aren't explicitly defined elsewhere, though it is a press release announcing a product milestone.
2015-11-18 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated November 18, 2015, announcing two key events: 1) The CE marking of a new procedure (BEAMOTION) by Theraclion, and 2) The presentation of this technology at a French senology congress. It details product advancements, clinical validation, and market access, which are typical components of corporate news releases. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). Since it is a general corporate announcement about a product milestone and market activity, it fits best under the general 'Regulatory Filings' (RNS) category, which often serves as a catch-all for significant, non-standardized corporate news releases, or potentially as a general 'Information' release if a more specific category existed. Given the provided definitions, RNS is the most appropriate fallback for a press release announcing a CE mark and conference participation.
2015-11-18 French
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated November 9, 2015, announcing business development activities in South Korea following a presidential visit. It details meetings with opinion leaders and commercial partners, and quotes the CEO regarding market expansion. This type of announcement, focusing on business updates, strategic progress, and market activities outside of mandatory financial reporting (like 10-K or IR) or specific corporate actions (like DIV or SHA), fits best under the general 'Regulatory Filings' (RNS) category, as it is an official communication to the market about operational progress, or potentially an Investor Presentation (IP) if it were a slide deck, but given the format, RNS is the most appropriate general disclosure category for non-standard corporate news. It is not an ER (Earnings Release), CT (Call Transcript), or a formal financial report (10-K, IR). Since it is a general corporate announcement/press release, RNS is the best fit among the provided options.
2015-11-09 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
M&A Activity Classification · 99% confidence The document is a press release dated November 9, 2015, announcing that the CEO of Theraclion accompanied the French President on a visit to South Korea, which facilitated business discussions and highlighted a commercial agreement. This type of announcement, detailing executive activities, business development, and market expansion efforts, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR, DIV). It is a general corporate announcement regarding business operations and strategic positioning. Since it is not a formal regulatory filing (like a 10-K or 8-K equivalent in the US context, which would map to RNS if no other category fits), and it is not about management changes (MANG) or director dealings (DIRS), the most appropriate general category for miscellaneous corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a broad catch-all for non-standard announcements.
2015-11-09 English
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is a press release from THERACLION dated November 3, 2015, announcing clinical routine treatments in Germany and the expansion of insurance coverage for its Echopulse system. It details business developments, market access achievements (insurance contracts), and quotes management. This content is characteristic of an announcement intended for investors and the public regarding operational and commercial progress, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general business update announcing commercial milestones and market access, it fits best under the general 'Regulatory Filings' (RNS) category as a broad corporate announcement, although it shares characteristics with an Investor Presentation (IP) or Earnings Release (ER) highlights, it lacks the formal structure of those specific reports. Given the options, RNS serves as the most appropriate catch-all for significant, non-standardized corporate news releases.
2015-11-03 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated November 3, 2015, from THERACLION, announcing clinical treatments and, more significantly, the expansion of insurance reimbursement coverage (Echopulse) by several German public insurance companies for thyroid nodules and breast adenofibromas. This type of announcement, detailing business developments, regulatory milestones (like insurance coverage expansion), and operational updates, is characteristic of a general corporate announcement or press release. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed interim report (IR). Since it is a general business update that doesn't fit the highly specific categories like DIRS, DIV, or CAP, the most appropriate classification is the general regulatory/corporate announcement fallback, RNS (Regulatory Filings), as it serves as a public disclosure of material business progress.
2015-11-03 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.